https://www.selleckchem.com/pr....oducts/o-pentagalloy
01), and percentage of patients who used basal insulin (47.9% vs. 31.3%, p less then 0.01) decreased. The proportion of patients who used diuretics also declined significantly. In addition, we observed improvement in glycemic control, with an increase in the proportion of patients with glycated hemoglobin less then 7% from 16.8% at three months to 63.5% at 12 (p less then 0.001). Canagliflozin use was also beneficial in terms of body weight, blood pressure, heart failure status, functional class, and cardiovascular-renal r
Me gusta
Comentario
Compartir
